(1)
Borroni, R. G.; Malagoli, P.; Gargiulo , L.; Valenti, M.; Pavia, G.; Facheris, P.; Morenghi, E.; di Corteranzo, I. G.; Narcisi, A.; Ortoncelli, M.; Dapavo, P.; Costanzo, A. Real-Life Effectiveness and Safety of Risankizumab in Moderate-to-Severe Plaque Psoriasis: A 40-Week Multicentric Retrospective Study. Acta Derm Venereol 2021, 101, adv00605.